These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 31348919)

  • 21. Peroxisome proliferator-activated receptor agonist (pioglitazone) with exogenous adiponectin ameliorates arterial stiffness and oxidative stress in diabetic Wistar Kyoto rats.
    Afzal S; Sattar MA; Johns EJ; Eseyin OA
    Eur J Pharmacol; 2021 Sep; 907():174218. PubMed ID: 34111396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Possible beneficial effect of peroxisome proliferator-activated receptor (PPAR)--α and γ agonist against a rat model of oral dyskinesia.
    Grover S; Kumar P; Singh K; Vikram V; Budhiraja RD
    Pharmacol Biochem Behav; 2013 Oct; 111():17-23. PubMed ID: 23948071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Memantine ameliorates autistic behavior, biochemistry & blood brain barrier impairments in rats.
    Kumar H; Sharma B
    Brain Res Bull; 2016 Jun; 124():27-39. PubMed ID: 27034117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lycopene ameliorates propionic acid-induced autism spectrum disorders by inhibiting inflammation and oxidative stress in rats.
    Erten F
    J Food Biochem; 2021 Oct; 45(10):e13922. PubMed ID: 34476820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel role of peroxisome proliferator activated receptor-α in valproic acid rat model of autism: Mechanistic study of risperidone and metformin monotherapy versus combination.
    Elnahas EM; Abuelezz SA; Mohamad MI; Nabil MM; Abdelraouf SM; Bahaa N; Hassan GAM; Aboul-Fotouh S
    Prog Neuropsychopharmacol Biol Psychiatry; 2022 Jun; 116():110522. PubMed ID: 35131336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peroxisome proliferator-activated receptor-γ activation attenuates harmaline-induced cognitive impairments in rats.
    Aghaei I; Hajali V; Haghani M; Vaziri Z; Moosazadeh M; Shabani M
    J Clin Neurosci; 2019 Jan; 59():276-283. PubMed ID: 30472346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repurposing of niclosamide, an anthelmintic, by targeting ERK/MAPK signaling pathway in the experimental paradigm of autism spectrum disorders.
    Singh Y; Sodhi RK; Kumar H; Bishnoi M; Bhandari R; Kuhad A
    Eur J Pharmacol; 2024 Nov; 982():176902. PubMed ID: 39153648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders.
    MacFabe DF; Cain DP; Rodriguez-Capote K; Franklin AE; Hoffman JE; Boon F; Taylor AR; Kavaliers M; Ossenkopp KP
    Behav Brain Res; 2007 Jan; 176(1):149-69. PubMed ID: 16950524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of the enteric bacterial metabolic product propionic acid on object-directed behavior, social behavior, cognition, and neuroinflammation in adolescent rats: Relevance to autism spectrum disorder.
    MacFabe DF; Cain NE; Boon F; Ossenkopp KP; Cain DP
    Behav Brain Res; 2011 Feb; 217(1):47-54. PubMed ID: 20937326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Smo-Shh signaling activator purmorphamine ameliorates neurobehavioral, molecular, and morphological alterations in an intracerebroventricular propionic acid-induced experimental model of autism.
    Rahi S; Gupta R; Sharma A; Mehan S
    Hum Exp Toxicol; 2021 Nov; 40(11):1880-1898. PubMed ID: 33906504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peroxisome Proliferator-Activated Receptor-gamma agonists exhibit anti-inflammatory and antiviral effects in an EcoHIV mouse model.
    Omeragic A; Kara-Yacoubian N; Kelschenbach J; Sahin C; Cummins CL; Volsky DJ; Bendayan R
    Sci Rep; 2019 Jul; 9(1):9428. PubMed ID: 31263138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathophysiological and neurobehavioral characteristics of a propionic acid-mediated autism-like rat model.
    Choi J; Lee S; Won J; Jin Y; Hong Y; Hur TY; Kim JH; Lee SR; Hong Y
    PLoS One; 2018; 13(2):e0192925. PubMed ID: 29447237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic treatment with the enteric bacterial metabolic product propionic acid results in reduction of social behavior in juvenile rats: Contribution to a rodent model of autism spectrum disorder.
    Shams S; Foley KA; Kavaliers M; MacFabe DF; Ossenkopp KP
    Dev Psychobiol; 2019 Jul; 61(5):688-699. PubMed ID: 30689218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vinpocetine ameliorates developmental hyperserotonemia induced behavioral and biochemical changes: role of neuronal function, inflammation, and oxidative stress.
    Luhach K; Kulkarni GT; Singh VP; Sharma B
    Acta Neurobiol Exp (Wars); 2022; 82(1):35-51. PubMed ID: 35451422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pioglitazone Ameliorates Lipopolysaccharide-Induced Behavioral Impairment, Brain Inflammation, White Matter Injury and Mitochondrial Dysfunction in Neonatal Rats.
    Yeh JH; Wang KC; Kaizaki A; Lee JW; Wei HC; Tucci MA; Ojeda NB; Fan LW; Tien LT
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intracerebroventricular injection of propionic acid, an enteric metabolite implicated in autism, induces social abnormalities that do not differ between seizure-prone (FAST) and seizure-resistant (SLOW) rats.
    Shultz SR; Aziz NA; Yang L; Sun M; MacFabe DF; O'Brien TJ
    Behav Brain Res; 2015 Feb; 278():542-8. PubMed ID: 25446754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The peroxisome proliferator-activated receptor-γ agonist pioglitazone protects against cisplatin-induced renal damage in mice.
    Jesse CR; Bortolatto CF; Wilhelm EA; Roman SS; Prigol M; Nogueira CW
    J Appl Toxicol; 2014 Jan; 34(1):25-32. PubMed ID: 22987311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peroxisome proliferator-activated receptor-γ agonist pioglitazone ameliorates white matter lesion and cognitive impairment in hypertensive rats.
    Lan LF; Zheng L; Yang X; Ji XT; Fan YH; Zeng JS
    CNS Neurosci Ther; 2015 May; 21(5):410-6. PubMed ID: 25611692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioral and biochemical investigations to explore pharmacological potential of PPAR-gamma agonists in vascular dementia of diabetic rats.
    Sharma B; Singh N
    Pharmacol Biochem Behav; 2011 Dec; 100(2):320-9. PubMed ID: 21893084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of PPAR-γ agonist pioglitazone on renal ischemia/reperfusion injury in rats.
    Reel B; Guzeloglu M; Bagriyanik A; Atmaca S; Aykut K; Albayrak G; Hazan E
    J Surg Res; 2013 Jun; 182(1):176-84. PubMed ID: 22981741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.